Rhumbline Advisers Bio Sig Technologies, Inc. Transaction History

Rhumbline Advisers

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$2.94 - $4.75 $56,480 - $91,252	-19,211 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$3.99 - $5.53 $3,990 - $5,530	1,000 Added 5.49%	19,211 $83,000
Q4 2020 Feb 10, 2021	BUY	$2.99 - $5.79 $5,382 - $10,422	1,800 Added 10.97%	18,211 $71,000
Q3 2020 Nov 12, 2020	SELL	$4.79 - $9.1 $7,448 - $14,150	-1,555 Reduced 8.66%	16,411 $81,000
Q2 2020 Aug 13, 2020	BUY	$3.61 - $11.84 $22,508 - $73,822	6,235 Added 53.15%	17,966 $129,000
Q4 2019 Feb 05, 2020	BUY	$5.78 - $8.11 $1,734 - $2,433	300 Added 2.62%	11,731 $69,000
Q3 2019 Oct 23, 2019	SELL	$6.55 - $9.36 $982 - $1,404	-150 Reduced 1.3%	11,431 $94,000
Q2 2019 Aug 14, 2019	BUY	$5.92 - $9.47 $68,559 - $109,672	11,581 New	11,581 $109,000

88.1K

Ticker BSGM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,814,400
Market Cap $60.1M
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.